PRESS RELEASE published on 12/04/2024 at 07:00, 1 year 7 months ago Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya Valneva SE annonce la publication d’un article sur l’impact sanitaire et économique mondial du chikungunya dans le British Medical Journal, mettant en lumière son lourd fardeau et ses coûts importants Valneva SE Chikungunya British Medical Journal Impact Sanitaire Coûts Économiques
BRIEF published on 11/26/2024 at 17:50, 1 year 7 months ago Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
BRIEF published on 11/26/2024 at 17:50, 1 year 7 months ago Valneva demande l'approbation de la FDA pour l'extension de son vaccin contre le chikungunya Valneva Adolescents Vaccin Contre Le Chikungunya Demande Auprès De La FDA Persistance Des Anticorps
PRESS RELEASE published on 11/26/2024 at 17:45, 1 year 7 months ago Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF published on 10/10/2024 at 07:05, 1 year 8 months ago Valneva présente ses perspectives lors d'une journée investisseurs à New York Croissance Investisseurs Valneva Vaccins Lyme
BRIEF published on 10/10/2024 at 07:05, 1 year 8 months ago Valneva presents its outlook at an investor day in New York Investors Growth Valneva Vaccines Lyme
PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 8 months ago Valneva organise une journée investisseurs aujourd’hui à New York Valneva organise une journée investisseurs à New York pour présenter ses activités vaccinales et stratégie de création de valeur. Des présentations sur leurs principaux projets de R&D seront diffusées en direct à 16h00 CET R&D Valneva Vaccins Journée Investisseurs Création De Valeur
PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 8 months ago Valneva Hosts Investor Day in New York City Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines
BRIEF published on 10/04/2024 at 07:35, 1 year 9 months ago Valneva SE Announces Changes in Shares and Voting Rights Euronext Paris Voting Rights Shares Capital Increase Valneva SE
BRIEF published on 10/04/2024 at 07:35, 1 year 9 months ago Valneva SE annonce des changements dans son actionnariat et ses droits de vote Euronext Paris Actions Augmentation De Capital Droit De Vote Valneva SE
Published on 07/03/2026 at 23:00, 14 hours 29 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 16 hours 1 minute ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 17 hours 59 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 23 hours 59 minutes ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 11:01, 2 hours 28 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 4 hours 24 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 18 hours 29 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 18 hours 34 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 19 hours 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 21:49, 15 hours 40 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 15 hours 40 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 18 hours 47 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 18 hours 53 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026